Adaptive Biotechnologies CorporationADPTNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +22.46% | +3.66% | +25.24% | +36.33% | +102.38% |
| Gross Profit Growth | +60.28% | +12.40% | +48.87% | +71.24% | +154.69% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.94% | +1.52% | +2.34% | +3.17% | +3.33% |
| Weighted Average Shares Diluted Growth | +1.94% | +1.52% | +2.34% | +3.17% | +10.61% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +30.77% | +9.91% | +3.72% | +24.36% | +13.49% |
| Inventory Growth | -38.66% | -41.58% | -34.66% | -36.41% | -16.91% |
| Asset Growth | -22.18% | -18.42% | -17.65% | -15.09% | -12.16% |
| Book Value per Share Growth | -39.32% | -35.25% | -32.32% | -27.90% | -11.59% |
| Debt Growth | -9.36% | -9.50% | -9.94% | -10.41% | +132.66% |
| R&D Expense Growth | -15.32% | -19.32% | -19.98% | -4.81% | -2.04% |
| SG&A Expenses Growth | -6.80% | -7.04% | -3.51% | +8.24% | +9.57% |